News

IDT (ASX: IDT) Secures its first Medicinal Cannabis Manufacturing Permit from the Office of Drug Control Read more about this update here.

IDT Australia Ltd (ASX: IDT) secures Medicinal Cannabis Manufacturing Licence from the Office of Drug Control. Read more about this News item here.

IDT Australia Ltd (ASX: IDT) has posted updates to its ASX Page. ASX Announcements

IDT Australia Ltd (ASX: IDT) has posted updates to its ASX Page.  IDT’s Annual General Meeting Presentation is also available to view on the below link. ASX Announcements

ASX Announcements  

IDT Australia Ltd (ASX: IDT) has posted updates to 4E, 4G & Corporate Governance.  IDT’s Annual Report has also available to view on the below link. ASX Announcements Corporate Governance  

IDT Australia Limited (ASX: IDT) provides the following market update that it has entered into a manufacturing agreement with Cann Group Limited (ASX: CAN). IDT has been contracted to provide manufacturing support in relation to medicinal cannabis‐based product formulations intended for supply to patients in Australia and overseas. “Cann Group has established itself as an…

IDT Australia Limited (IDT) provides the following market update regarding the meeting held with the U.S. Food and Drug Administration (FDA) in Washington on 24 July 2018. Ms Michelle Coffey and Dr David Sparling, along with IDT’s U.S. based specialist consultants today attended a meeting with representatives from the FDA’s Office of Manufacturing Quality. The…

In keeping with the Company’s recently announced Generics Strategy, whereby IDT is to advance a selected generics portfolio and to build on the Company’s existing Commercial API and Contract Manufacturing businesses, IDT Australia has divested a majority of the Company’s generic ANDA product portfolio to ANI Pharmaceuticals Inc. Under the terms of the divestment, IDT…

IDT Australia Limited (IDT) announces the appointment of Dr David Sparling as interim Chief Executive Officer. Dr Sparling is currently Vice President of Corporate & Business Development at IDT and brings a wealth of experience in the pharmaceutical industry to the role.